- Home
- LGCB vs SBFM Comparison
LGCB vs SBFM Comparison
Compare LGCB & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- SBFM
- Stock Information
- Founded
- LGCB 2011
- SBFM 2006
- Country
- LGCB Japan
- SBFM United States
- Employees
- LGCB N/A
- SBFM N/A
- Industry
- LGCB
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- SBFM Health Care
- Exchange
- LGCB Nasdaq
- SBFM Nasdaq
- Market Cap
- LGCB 7.8M
- SBFM 6.8M
- IPO Year
- LGCB 2023
- SBFM N/A
- Fundamental
- Price
- LGCB $0.23
- SBFM $2.45
- Analyst Decision
- LGCB
- SBFM Strong Buy
- Analyst Count
- LGCB 0
- SBFM 1
- Target Price
- LGCB N/A
- SBFM $15.00
- AVG Volume (30 Days)
- LGCB 196.7K
- SBFM 52.5K
- Earning Date
- LGCB 03-11-2025
- SBFM 03-27-2025
- Dividend Yield
- LGCB N/A
- SBFM N/A
- EPS Growth
- LGCB N/A
- SBFM N/A
- EPS
- LGCB N/A
- SBFM N/A
- Revenue
- LGCB $10,289,681.00
- SBFM $32,959,491.00
- Revenue This Year
- LGCB N/A
- SBFM $59.94
- Revenue Next Year
- LGCB N/A
- SBFM $164.69
- P/E Ratio
- LGCB N/A
- SBFM N/A
- Revenue Growth
- LGCB N/A
- SBFM 61.94
- 52 Week Low
- LGCB $0.17
- SBFM $2.11
- 52 Week High
- LGCB $5.71
- SBFM $286.00
- Technical
- Relative Strength Index (RSI)
- LGCB 38.08
- SBFM 38.35
- Support Level
- LGCB $0.22
- SBFM $2.39
- Resistance Level
- LGCB $0.28
- SBFM $2.58
- Average True Range (ATR)
- LGCB 0.02
- SBFM 0.15
- MACD
- LGCB 0.00
- SBFM -0.01
- Stochastic Oscillator
- LGCB 24.85
- SBFM 14.89
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Copany operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.